N/A
N=253
Patent Hemostasis With Vasoband Versus TR Band
Radial Artery Injury at Wrist and Hand Level
Bottom Line
View on ClinicalTrials.gov: NCT04002791 ↗Enrolled (actual)
253
Serious AEs
7.1%
Results posted
Nov 2020
Primary outcome: Primary: Number of Patients Who Achieved Patent Hemostasis — 94; 122 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- VasoBand (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Total Cardiovascular Solutions
- Primary completion
- Oct 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patients Who Achieved Patent Hemostasis |
94; 122 | — |
| SECONDARY Number of Participants With Radial Artery Occlusion One Hour After Removal of Hemostatic Compression |
13; 2 | — |
Summary
In patients referred for cardiac catheterization to be performed using transradial access, a randomized comparison will be performed with the primary endpoint of patency of radial artery at the time of application of hemostatic compression band. The single radial only TR-Band (Terumo, Japan) will be compared to the dual balloon Vasoband (Vasoinnovations, USA) capable of ipsilateral ulnar artery compression.
Eligibility Criteria
Inclusion Criteria
- Patients referred for cardiac catheterization undergoing transradial access
Exclusion Criteria
- Previous ipsilateral radial artery cannulation, oral systemic anticoagulation therapy, thrombolytic therapy in the previous 7 days.
Data sourced from ClinicalTrials.gov (NCT04002791). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.